current user: public

Please be advised that we have recently moved our server to a new location. We tried our best to fully test all functions on the website, but if something does not work for you please let us know.

Query: gi|60683330|ref|YP_213474.1| ATP-dependent protease ATP-binding subunit ClpX (BF3893) [Bacteroides fragilis NCTC 9343] (Range: 1-415), from B.fragilis

Results of FFAS03 search in PfamA32U
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .
# Score Template Links and tools%idFirst MAESKNNKKRCSFCGRSENEVGFLITGMNGYICDSCATQAYEITQEAMGAGKQSAGATRLNLKELPKPVEIKNFLDQYVIGQDDAKRFLAVSVYNHYKRLLQKDSGDDVEIEKSNIIMVGSTGTGKTLLARTIAKLLHVPFTIVDATVLTEAGYVGEDIESILTRLLQVADYNVPEAEQGIVFIDEIDKIARKGDNPSITRDVSGEGVQQGLLKLLEGSVVNVPPQGGRKHPDQKMIPVNTKNILFICGGAFDGIEKKIAQRLNTHVVGYNASRKTATIDKNNMMQYIAPQDLKSFGLIPEIIGRLPVLTYLNPLDRNALRAILTEPKNSIIKQYIKLFEMDGVKLTFQPEVYEYIVDKAVEYKLGARGLRSIVETIMMDVMFEIPSEDQKEYEVTLDYAKHQLEKANLARLQTALast
1 -32.300PF07724.14; Q7PAG5_RICSI/595-759; AAA domain (Cdc48 subfamily)  ali follow..  15  1..............................................................................................................RPLGSFLFLGPTGVGKTELTKALAGFL-----FDDRNAILRIDMSEYMEKHAISRL-----------------IGAPPGYIGYDQGGVLTEAVRRRPYQVILFDEVEKAHPDIFNIMLQILDEGRLTDSQGITVDFKNTIIVLTSNLGAEILVN------------QKEDEDTYKVKDEVMEYVKAVFKPEFLNRLDEI.......................................................................................................... 165
2 -20.200PF05496.12; RUVB_BACAN/21-179; Holliday junction DNA helicase RuvB P-loop domain  ali follow..  23  2..................................................................RPQTLRQ-----YIGQDKAKHNLEVFIEAAKMR----------EETLDHVLLYGPPGLGKTTLANIIANEMGVNVRTTSGPAIERPGDLAAVLTSL--------------QPGDVLFIDEIHRL--------------HRSIEEVLYPAMEDFCLDI---VIGKGPSARSVRLDLPPFTLVGA...................................................................................................................................................................... 138
3 -19.900PF06309.11; O45271_CAEEL/5-130; Torsin  ali follow..  15  8............................................................FETDIFDYLKLHRDLSRFIYGQHLVIDTVVRSIKSHWHNEHPQKPLV--------LSFHGGPGTGKNYVTEIIAKNTFRSGLQSPYVKYFVATKNNKHIEDYKLKLKEQLIQSADGCDRSIFVF....................................................................................................................................................................................................................................... 126
4 -18.100PF10431.9; Q118T1_TRIEI/770-850; C-terminal, D2-small domain, of ClpB protein  ali follow..  16  1..........................................................................................................................................................................................................................................................................................................................LQKEQLREIVQL----QVVRLEKRLAERKMSLKLTDAAINFLADVGYDPVYGARPLKRAIQRELETQIAK............................... 66
5 -14.700PF00004.29; LON_BRECH/351-493; ATPase family associated with various cellular activities (AAA)  ali follow..  23  1...................................................................................................................LCLVGPPGVGKTSLARSVARALGREFVRISLGGVRDEAEIRGHRRTYVGALPGRIIQGMKQAINPVFLLDEIDKLASDFRGDPAS----------ALLEVLD------PNQNDKFSDHYIEETYDLTNVMFITTA..................................................................................................................................................................... 121
6 -14.200PF06068.13; RUVB2_CAEEL/17-361; TIP49 P-loop domain  ali follow..  15  26..............................................................................MVGQVAARQAAGLIV----------KMIQEGKIAGRALLVTGEPGAGKTAIAIAISKELGEDTPFVSIVA-SEIYSNEINKTEALTQAFRRA---------GIQIKEETEVLEGEVISLEVDRSANGMGPKVGKLTMRTTDMETIYDLGSKMVDACLKEKVMPGDVIQVASGRVTRLGRSFNRSHDYDA----PKVKLVQCPDGEIQKRRETVHTVCLHDIDVINSRTQGYVALFSGDTGEIKAEVRDQINKKVLEWRE.............................................................................. 263
7 -14.200PF05673.13; Q0K6N5_CUPNH/29-287; Protein of unknown function (DUF815 topsan)  ali follow..  15  33............................................................................DDLKNIERQKDAIVANTRQFVSK-----------LPANNVLLTGARGTGKSSLIKACLNAFV-----RDGLRLVEVD------KDDLGDLGDIVELVAQRPERFVIFCDDLS--------------EEGESGYKSLKSALDGS-----------------VAAQSDNVLIYAT----------SNRRHLLPEYMKDNETYRHTDDGEIHPGEVVEEKIS------LSERFGLWLSFYPPKQDEYLAIV-----------GHWLRHFGCTDEDIAAARGDALVWALERSRSGRVAWQFARDWG..................................... 256
8 -13.900PF01078.21; Q8EJV7_SHEON/193-396; Magnesium chelatase, subunit ChlI  ali follow..  20  5..............................................................................VIGQYQAKQALEIAAAGNH-----------------NLLMLGPPGTGKTMLASRMMALL--ALNYEEALEVARAPHHTCSSISLVGGGSIPKPGEISLAHRGVLFLDEVAEF--------------PRKVLDCLREPMETGEVVISRAAAKLTFLSRFQLIAAMN-----------------------PSGDIDGPNRATPDQIQRYLA----------LSGPFIDRFDLTIEVPKLPAGTL............................................................................................... 204
9 -12.200PF13177.6; A5VIC8_LACRD/13-171; DNA polymerase III, delta subunit  ali follow..  16  1.................................................................................QPAIITRFQKILSNNELA--------------HAYLFVGPGGSGKMSIAQWLSLRLFQRILSGNHPDIVYAAPEGRQIKDEIRRLKAEFSKSAVEGNKKIFIIKDADKMTNGAAN--------------SLLKFIEEPGAGVYIFMLTTNKSAVLPTIRSR............................................................................................................................................................................. 150
10 -11.800PF08298.11; YEAG_ECOLI/19-380; PrkA AAA domain  ali follow..  12  58............................................................................EEFYGMEDAIEQIVSYLKHAAQGL---------EEKKQILYLLGPVGGGKSSLAERLKSLMQ-PFCLFNPQEDAQI--PGDENNQDISALVGKVDGALCRANQGIMEFVEMFKA--------------PIKVLHPLLTATQEGNYNG---------TEGISALPFNGIILAHS------------------------------------NESEWVTFRNNKNNEAFLDRVYIVKVPYCLRISEEIKIYE----------KLLNHSELTHAPCAPGTLETLSRFSILSRL.................................................. 355
11 -11.400PF03215.15; RAD24_YEAST/58-237; Rad17 P-loop domain  ali follow..  11...............................................................EKFKPNCLEQ-----VAIHKRKLKDVQEALDAMFLP----------NAKHRILLLSGPSGCSKSTVIKELSKILVPKYR-HKVTEFRGDCIVNDLPQMESFSEFLKGARYLVMSNLSLILIEDLPNVFHIDTRRRFQQLILQ.................................................................................................................................................................................................................. 150
12 -10.700PF00158.26; Q8E8E7_SHEON/154-320; Sigma-54 interaction domain  ali follow..  23  1..............................................................................IIGSSDAMKSVKQVI-------------ERVAPTNAVVLIQGESGTGKELVARQLHLL---PFVPVNCGSLLESELFGH-TAGAFTGAKGNREGLFSFASGGTIFLDEIGEMP---------------KMQTALLRVLEQKAIRPVGSEKEVNIDVRVIAATNRTL........................................................................................................................................................................... 144
13 -10.600PF07726.11; Q87G66_VIBPA/36-166; ATPase family associated with various cellular activities (AAA)  ali follow..  22  1..................................................................................................................HILVEGPPGLAKTRAVKSLSDCVEGDFHRIQFTPLLPADLTGTDIFRPETGEFTFQSGPI----NSLILADEINRAPAK--------------VQAAMLEAMAEKQVTA................................................................................................................................................................................................ 93
14 -10.500PF00493.23; MCM2_YEAST/480-703; MCM P-loop domain  ali follow..  15  16....................................................................DKIISSMAPSIYGHRDIKTAVACSL---FGGVPKNVNGKHSIRGDINVLLLGDPGTAKSQILKYVEKTA----VFATGQGASAVGLTASVRKDPITKEWTLEGGALVLADKGVCLIDEFDKMNDQD--------------RTSIHEAMEQQSISISK-----------------------AGIVTTLQARCSIIAAANPNGGRYNSTLPLAQ--------------NVSLTEPILSRFDILCVVRDLVDEEADERLAT......................................................................................... 218
15 -10.500PF13401.6; B2UJB3_RALPJ/42-210; AAA domain  ali follow..  20  1.............................................................................................................DSQESILLVCGPTGAGKTTLAKFMVENA-IPAIYVQAPASGETKFSWRLFGNSLAALRTAVERGLRARQVQFMVIDEAAHIFRDTQRNSKLEVQ-----LDTLKSLVNECGTQI................................................................................................................................................................................................ 157
16 -10.200PF07931.12; Q98FG2_RHILO/59-238; Chloramphenicol phosphotransferase-like protein  ali follow..  25  1.................................................................................................................ARIVLLGVGSAGKSSIARALQTITAAPFLHVQMDSFLEM....................................................................................................................................................................................................................................................................... 40
17 -10.200PF13173.6; F9Z5R0_ODOSD/18-152; AAA domain  ali follow..  18  1................................................................................................................RKPLILNGARQVGKTWLLHEFAKLEYKKEAYVVKNNLARQLFSQDFNVDRILRGLRAMTSVDITPGDTLIILDEIQDIPEALESLKYFKEEVPE--------AVAGSLLGISLHQDVSYPVGKVNVINIFPMNF......................................................................................................................................................................... 131
18 -10.000PF13521.6; A4CIV1_ROBBH/14-173; AAA domain  ali follow..  20  1..................................................................................................................KVVLFGPESTGKTTLARELARHYGEPWVPEYAREYLQEKWDRVQQTCAPEDLLPIARGQMRLENIRLLICDT..................................................................................................................................................................................................................................... 78
19 -9.990PF13238.6; A0B5Y2_METTP/3-117; AAA domain  ali follow..  35  1...................................................................................................................IALTGTPGTGKTTVSGLLPF........................................................................................................................................................................................................................................................................................ 20
20 -9.780PF05621.11; B7J739_ACIF2/21-211; Bacterial TniB protein  ali follow..  16  1.....................................................................RMAFLDEPRWIGYAQANRLLDNL---------RSLMEKPVRPRMPNLLIVGDSNNGKTTVIRRFQKLH-VPVIVSEAIAILERFWTPYRATDSASKLRYQVVHLMRDCHVRILVIDEFHSLLTGTVT-------KQREVMNAIKLLCNELAIPI................................................................................................................................................................................................ 157
21 -9.620PF01637.18; A8M939_CALMQ/15-228; ATPase domain predominantly from Archaea  ali follow..  1..............................................................................FTDREVAIRQIEKLAEKGTWNP---------------VVIYGPEGCGKSAFLKQAVEVLSVVKVSPLEDESNEKLRYSEELRGLFRDIMTRIPTPFNIRRKIALLADDVFQAIGLDKAELLVKRLLN.................................................................................................................................................................................................................. 137
22 -9.600PF03266.15; NTPTH_METAC/3-167; NTPase  ali follow..  17  1..................................................................................................................RIAVTGSPGVGKSTVVAKTAEKL------AEKPGFKIGGIRGHREGFSIRDLATGKTGILNALACDLVVIDEIGPM-----------ELISQSFVSAVEEVLESDKPSRHPLAQRFRKGFEVLTVDKGN............................................................................................................................................................................ 156
23 -9.590PF17213.3; F6ZLU4_XENTR/1991-2193; Hydin Adenylate kinase-like domain  ali follow..  26  2...................................................................................................................IIVHGAPLTGKSSAAVTLAQHYNIPCLSIDSVVLDAISDSNSPTGMRARQLCSKAAFDVALRE............................................................................................................................................................................................................................................. 64
24 -9.480PF10923.8; B0C6J3_ACAM1/7-410; P-loop Domain of unknown function (DUF2791 topsan)  ali follow..  11  20.......................................................................RKGQHLIQVGRAEEIKAILRDIERIAEG------------GAAIRFIIGEYGSGKTFFINLTRTIAKLVTAHADLTPDRRLHASSGQARSLYTELMANLSTRTKPDGGALPSVERLAHLSEFVGGYDFSEVIGDDALKANAVRWLRGEFSTKTEARSALGVRTIVDDTNVYDQLLVKLAGYDGFMICLDELVNLYKLSNTQARKSNYEQILRILNDCLQGTAGHLGFMPALQTRLAEVLRLANLSPEDLYVLLG-------KIRLVFAEGNMKKSRLPDQGIQAFMAHCSDYEAYFRTPRNTIKAFVDAVLEQNTQVSWKDLITKVN................. 404
25 -9.400PF06689.13; R6J2X8_9CLOT/11-48; ClpX C4-type zinc finger  ali follow..  45  2.........RCSFCGKSEAMVHKLIEGPGVFICDECIRLCNDLIQS................................................................................................................................................................................................................................................................................................................................................................................. 38
26 -9.190PF14532.6; C6X8G9_METGS/136-273; Sigma-54 interaction domain  ali follow..  19  1...............................................................................LGKSPVISELRQRL-------------EQIAGVKSPLLLIGEQGSGAELCAKFLPDTPWLSLTDYEQLATAPLDI-------------------LEQVQEGMLFIPEVADLS--------------KNQQKGLQLLLARAD................................................................................................................................................................................................... 97
27 -9.140PF00910.22; A7M6L1_9SECO/473-576; RNA helicase  ali follow..  19  1...................................................................................................................VYAYGESRTGKTLVVDKLITDFQNHFGLGKDTVYSRNGYRRQP----------------------IVSIDDFGAVTCDPSM-------------AQMIPLVSSAPLPL-----------TMAAIEEKGMMFDSKFIFCSSN............................................................................................................................................................... 103

FFAS is supported by the NIH grant R01-GM087218-01
1 2 6 4 9 8   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Friedberg I, Godzik A. Fragnostic: walking through protein structure space. Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W249-51.